Skip to content

Advertisement

  • Oral presentation
  • Open Access

Development of a SMCs model from HGPS-iPS and proofs of principle

Orphanet Journal of Rare Diseases201510(Suppl 2):O3

https://doi.org/10.1186/1750-1172-10-S2-O3

Published: 11 November 2015

Keywords

  • Stem Cell
  • Smooth Muscle
  • Muscle Cell
  • Molecular Mechanism
  • Smooth Muscle Cell

HGPS is a rare, progressive aging disease in children that leads to premature death. Vascular smooth muscle cells (SMCs) are the most affected cells in HGPS patients, although the reason for such sensitivity remains poorly understood. Induced pluripotent stem cells (iPSCs) offer an unlimited source of SMCs to study the disease. iPSCs are also an important tool to study the molecular mechanisms of the disease from a developmental point of view. In this work, we study the reasons of HGPS-SMCs vulnerability using iPSCs obtained from HGPS fibroblast patients. We have evaluated the differentiation profile of HGPS-iPSCs and normal iPSCs into SMCs. We showed that HGPS-iPSC SMCs shared similar features observed on progerin-expressing cells. We have identified and characterize drugs that prevent SMC loss. Our findings open new opportunities for the treatment of HGPS disease and diseases related to vascular ageing.

Authors’ Affiliations

(1)
Center of Neurosciences and Cell Biology, University of Coimbra, Portugal

Copyright

© Ferreira 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement